Circulating Branched Chain Amino Acids and Cardiometabolic Disease.
Keenan S FineJohn T WilkinsKonrad Teodor SawickiPublished in: Journal of the American Heart Association (2024)
Branched chain amino acids (BCAAs) are essential for protein homeostasis, energy balance, and signaling pathways. Changes in BCAA homeostasis have emerged as pivotal contributors in the pathophysiology of several cardiometabolic diseases, including type 2 diabetes, obesity, hypertension, atherosclerotic cardiovascular disease, and heart failure. In this review, we provide a detailed overview of BCAA metabolism, focus on molecular mechanisms linking disrupted BCAA homeostasis with cardiometabolic disease, summarize the evidence from observational and interventional studies investigating associations between circulating BCAAs and cardiometabolic disease, and offer valuable insights into the potential for BCAA manipulation as a novel therapeutic strategy for cardiometabolic disease.
Keyphrases
- type diabetes
- cardiovascular disease
- amino acid
- heart failure
- blood pressure
- metabolic syndrome
- insulin resistance
- signaling pathway
- atrial fibrillation
- oxidative stress
- risk assessment
- left ventricular
- coronary artery disease
- climate change
- glycemic control
- small molecule
- cardiovascular risk factors
- cardiac resynchronization therapy
- high fat diet induced